img

Global Immune Globulin Intravenous Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Immune Globulin Intravenous Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Immune globulin (Ig) short-term protection against hepatitis A and measles
Immune Globulin Intravenous report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Immune Globulin Intravenous market is projected to reach US$ 21770 million in 2029, increasing from US$ 13360 million in 2022, with the CAGR of 7.1% during the period of 2024 to 2029. Demand from Immunodeficiency and Autoimmune Disease are the major drivers for the industry.
The market growth can be attributed to several factors. Firstly, the increasing prevalence of bleeding disorders, driven by factors such as genetic predisposition, aging population, and improved diagnostic capabilities, has fueled the demand for coagulation factor products. Additionally, advancements in recombinant DNA technology and biotechnology have enabled the development of highly purified and more effective coagulation factor concentrates, offering improved treatment options for patients.Furthermore, the rising awareness about bleeding disorders and the availability of comprehensive treatment programs have contributed to increased diagnosis rates and access to coagulation factor therapies. Improved reimbursement policies and healthcare infrastructure have also played a role in expanding market reach.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Immune Globulin Intravenous market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Takeda
Grifols
CSL
Octapharma
Biotest
Kedrion
Hualan Bio
CNBG
Shanghai RAAS
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang
Segment by Type
IVIg Liquid
IVIg Powder

Segment by Application


Immunodeficiency
Autoimmune Disease
Acute Infection

Segment by Region


North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Immune Globulin Intravenous market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Immune Globulin Intravenous, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Immune Globulin Intravenous industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Immune Globulin Intravenous in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Immune Globulin Intravenous introduction, etc. Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Immune Globulin Intravenous market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Immune Globulin Intravenous Market Overview
1.1 Immune Globulin Intravenous Product Overview
1.2 Immune Globulin Intravenous Market Segment by Type
1.2.1 IVIg Liquid
1.2.2 IVIg Powder
1.3 Global Immune Globulin Intravenous Market Size by Type
1.3.1 Global Immune Globulin Intravenous Market Size Overview by Type (2018-2029)
1.3.2 Global Immune Globulin Intravenous Historic Market Size Review by Type (2018-2024)
1.3.3 Global Immune Globulin Intravenous Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Immune Globulin Intravenous Sales Breakdown by Type (2018-2024)
1.4.2 Europe Immune Globulin Intravenous Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Immune Globulin Intravenous Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Immune Globulin Intravenous Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Immune Globulin Intravenous Sales Breakdown by Type (2018-2024)
2 Global Immune Globulin Intravenous Market Competition by Company
2.1 Global Top Players by Immune Globulin Intravenous Sales (2018-2024)
2.2 Global Top Players by Immune Globulin Intravenous Revenue (2018-2024)
2.3 Global Top Players by Immune Globulin Intravenous Price (2018-2024)
2.4 Global Top Manufacturers Immune Globulin Intravenous Manufacturing Base Distribution, Sales Area, Product Type
2.5 Immune Globulin Intravenous Market Competitive Situation and Trends
2.5.1 Immune Globulin Intravenous Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Immune Globulin Intravenous Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Immune Globulin Intravenous as of 2022)
2.7 Date of Key Manufacturers Enter into Immune Globulin Intravenous Market
2.8 Key Manufacturers Immune Globulin Intravenous Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Immune Globulin Intravenous Status and Outlook by Region
3.1 Global Immune Globulin Intravenous Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Immune Globulin Intravenous Historic Market Size by Region
3.2.1 Global Immune Globulin Intravenous Sales in Volume by Region (2018-2024)
3.2.2 Global Immune Globulin Intravenous Sales in Value by Region (2018-2024)
3.2.3 Global Immune Globulin Intravenous Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Immune Globulin Intravenous Forecasted Market Size by Region
3.3.1 Global Immune Globulin Intravenous Sales in Volume by Region (2024-2029)
3.3.2 Global Immune Globulin Intravenous Sales in Value by Region (2024-2029)
3.3.3 Global Immune Globulin Intravenous Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Immune Globulin Intravenous by Application
4.1 Immune Globulin Intravenous Market Segment by Application
4.1.1 Immunodeficiency
4.1.2 Autoimmune Disease
4.1.3 Acute Infection
4.2 Global Immune Globulin Intravenous Market Size by Application
4.2.1 Global Immune Globulin Intravenous Market Size Overview by Application (2018-2029)
4.2.2 Global Immune Globulin Intravenous Historic Market Size Review by Application (2018-2024)
4.2.3 Global Immune Globulin Intravenous Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Immune Globulin Intravenous Sales Breakdown by Application (2018-2024)
4.3.2 Europe Immune Globulin Intravenous Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Immune Globulin Intravenous Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Immune Globulin Intravenous Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Immune Globulin Intravenous Sales Breakdown by Application (2018-2024)
5 North America Immune Globulin Intravenous by Country
5.1 North America Immune Globulin Intravenous Historic Market Size by Country
5.1.1 North America Immune Globulin Intravenous Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Immune Globulin Intravenous Sales in Volume by Country (2018-2024)
5.1.3 North America Immune Globulin Intravenous Sales in Value by Country (2018-2024)
5.2 North America Immune Globulin Intravenous Forecasted Market Size by Country
5.2.1 North America Immune Globulin Intravenous Sales in Volume by Country (2024-2029)
5.2.2 North America Immune Globulin Intravenous Sales in Value by Country (2024-2029)
6 Europe Immune Globulin Intravenous by Country
6.1 Europe Immune Globulin Intravenous Historic Market Size by Country
6.1.1 Europe Immune Globulin Intravenous Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Immune Globulin Intravenous Sales in Volume by Country (2018-2024)
6.1.3 Europe Immune Globulin Intravenous Sales in Value by Country (2018-2024)
6.2 Europe Immune Globulin Intravenous Forecasted Market Size by Country
6.2.1 Europe Immune Globulin Intravenous Sales in Volume by Country (2024-2029)
6.2.2 Europe Immune Globulin Intravenous Sales in Value by Country (2024-2029)
7 Asia-Pacific Immune Globulin Intravenous by Region
7.1 Asia-Pacific Immune Globulin Intravenous Historic Market Size by Region
7.1.1 Asia-Pacific Immune Globulin Intravenous Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Immune Globulin Intravenous Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Immune Globulin Intravenous Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Immune Globulin Intravenous Forecasted Market Size by Region
7.2.1 Asia-Pacific Immune Globulin Intravenous Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Immune Globulin Intravenous Sales in Value by Region (2024-2029)
8 Latin America Immune Globulin Intravenous by Country
8.1 Latin America Immune Globulin Intravenous Historic Market Size by Country
8.1.1 Latin America Immune Globulin Intravenous Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Immune Globulin Intravenous Sales in Volume by Country (2018-2024)
8.1.3 Latin America Immune Globulin Intravenous Sales in Value by Country (2018-2024)
8.2 Latin America Immune Globulin Intravenous Forecasted Market Size by Country
8.2.1 Latin America Immune Globulin Intravenous Sales in Volume by Country (2024-2029)
8.2.2 Latin America Immune Globulin Intravenous Sales in Value by Country (2024-2029)
9 Middle East and Africa Immune Globulin Intravenous by Country
9.1 Middle East and Africa Immune Globulin Intravenous Historic Market Size by Country
9.1.1 Middle East and Africa Immune Globulin Intravenous Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Immune Globulin Intravenous Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Immune Globulin Intravenous Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Immune Globulin Intravenous Forecasted Market Size by Country
9.2.1 Middle East and Africa Immune Globulin Intravenous Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Immune Globulin Intravenous Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Takeda
10.1.1 Takeda Company Information
10.1.2 Takeda Introduction and Business Overview
10.1.3 Takeda Immune Globulin Intravenous Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Takeda Immune Globulin Intravenous Products Offered
10.1.5 Takeda Recent Development
10.2 Grifols
10.2.1 Grifols Company Information
10.2.2 Grifols Introduction and Business Overview
10.2.3 Grifols Immune Globulin Intravenous Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Grifols Immune Globulin Intravenous Products Offered
10.2.5 Grifols Recent Development
10.3 CSL
10.3.1 CSL Company Information
10.3.2 CSL Introduction and Business Overview
10.3.3 CSL Immune Globulin Intravenous Sales, Revenue and Gross Margin (2018-2024)
10.3.4 CSL Immune Globulin Intravenous Products Offered
10.3.5 CSL Recent Development
10.4 Octapharma
10.4.1 Octapharma Company Information
10.4.2 Octapharma Introduction and Business Overview
10.4.3 Octapharma Immune Globulin Intravenous Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Octapharma Immune Globulin Intravenous Products Offered
10.4.5 Octapharma Recent Development
10.5 Biotest
10.5.1 Biotest Company Information
10.5.2 Biotest Introduction and Business Overview
10.5.3 Biotest Immune Globulin Intravenous Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Biotest Immune Globulin Intravenous Products Offered
10.5.5 Biotest Recent Development
10.6 Kedrion
10.6.1 Kedrion Company Information
10.6.2 Kedrion Introduction and Business Overview
10.6.3 Kedrion Immune Globulin Intravenous Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Kedrion Immune Globulin Intravenous Products Offered
10.6.5 Kedrion Recent Development
10.7 Hualan Bio
10.7.1 Hualan Bio Company Information
10.7.2 Hualan Bio Introduction and Business Overview
10.7.3 Hualan Bio Immune Globulin Intravenous Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Hualan Bio Immune Globulin Intravenous Products Offered
10.7.5 Hualan Bio Recent Development
10.8 CNBG
10.8.1 CNBG Company Information
10.8.2 CNBG Introduction and Business Overview
10.8.3 CNBG Immune Globulin Intravenous Sales, Revenue and Gross Margin (2018-2024)
10.8.4 CNBG Immune Globulin Intravenous Products Offered
10.8.5 CNBG Recent Development
10.9 Shanghai RAAS
10.9.1 Shanghai RAAS Company Information
10.9.2 Shanghai RAAS Introduction and Business Overview
10.9.3 Shanghai RAAS Immune Globulin Intravenous Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Shanghai RAAS Immune Globulin Intravenous Products Offered
10.9.5 Shanghai RAAS Recent Development
10.10 CBPO
10.10.1 CBPO Company Information
10.10.2 CBPO Introduction and Business Overview
10.10.3 CBPO Immune Globulin Intravenous Sales, Revenue and Gross Margin (2018-2024)
10.10.4 CBPO Immune Globulin Intravenous Products Offered
10.10.5 CBPO Recent Development
10.11 LFB Group
10.11.1 LFB Group Company Information
10.11.2 LFB Group Introduction and Business Overview
10.11.3 LFB Group Immune Globulin Intravenous Sales, Revenue and Gross Margin (2018-2024)
10.11.4 LFB Group Immune Globulin Intravenous Products Offered
10.11.5 LFB Group Recent Development
10.12 BPL
10.12.1 BPL Company Information
10.12.2 BPL Introduction and Business Overview
10.12.3 BPL Immune Globulin Intravenous Sales, Revenue and Gross Margin (2018-2024)
10.12.4 BPL Immune Globulin Intravenous Products Offered
10.12.5 BPL Recent Development
10.13 Sichuan Yuanda Shuyang
10.13.1 Sichuan Yuanda Shuyang Company Information
10.13.2 Sichuan Yuanda Shuyang Introduction and Business Overview
10.13.3 Sichuan Yuanda Shuyang Immune Globulin Intravenous Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Sichuan Yuanda Shuyang Immune Globulin Intravenous Products Offered
10.13.5 Sichuan Yuanda Shuyang Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Immune Globulin Intravenous Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Immune Globulin Intravenous Industrial Chain Analysis
11.4 Immune Globulin Intravenous Market Dynamics
11.4.1 Immune Globulin Intravenous Industry Trends
11.4.2 Immune Globulin Intravenous Market Drivers
11.4.3 Immune Globulin Intravenous Market Challenges
11.4.4 Immune Globulin Intravenous Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Immune Globulin Intravenous Distributors
12.3 Immune Globulin Intravenous Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of IVIg Liquid
Table 2. Major Company of IVIg Powder
Table 3. Global Immune Globulin Intravenous Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 4. Global Immune Globulin Intravenous Sales by Type (2018-2024) & (K Units)
Table 5. Global Immune Globulin Intravenous Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Immune Globulin Intravenous Sales by Type (2018-2024) & (US& Million)
Table 7. Global Immune Globulin Intravenous Market Share in Value by Type (2018-2024)
Table 8. Global Immune Globulin Intravenous Price by Type (2018-2024) & (USD/Unit)
Table 9. Global Immune Globulin Intravenous Sales by Type (2024-2029) & (K Units)
Table 10. Global Immune Globulin Intravenous Sales Market Share in Volume by Type (2024-2029)
Table 11. Global Immune Globulin Intravenous Sales by Type (2024-2029) & (US$ Million)
Table 12. Global Immune Globulin Intravenous Sales Market Share in Value by Type (2024-2029)
Table 13. Global Immune Globulin Intravenous Price by Type (2024-2029) & (USD/Unit)
Table 14. North America Immune Globulin Intravenous Sales by Type (2018-2024) & (K Units)
Table 15. North America Immune Globulin Intravenous Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Immune Globulin Intravenous Sales (K Units) by Type (2018-2024)
Table 17. Europe Immune Globulin Intravenous Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Immune Globulin Intravenous Sales (K Units) by Type (2018-2024)
Table 19. Asia-Pacific Immune Globulin Intravenous Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Immune Globulin Intravenous Sales (K Units) by Type (2018-2024)
Table 21. Latin America Immune Globulin Intravenous Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Immune Globulin Intravenous Sales (K Units) by Type (2018-2024)
Table 23. Middle East and Africa Immune Globulin Intravenous Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Immune Globulin Intravenous Sales by Company (2018-2024) & (K Units)
Table 25. Global Immune Globulin Intravenous Sales Share by Company (2018-2024)
Table 26. Global Immune Globulin Intravenous Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Immune Globulin Intravenous Revenue Share by Company (2018-2024)
Table 28. Global Market Immune Globulin Intravenous Price by Company (2018-2024) & (USD/Unit)
Table 29. Global Immune Globulin Intravenous Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Immune Globulin Intravenous Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Immune Globulin Intravenous as of 2022)
Table 32. Date of Key Manufacturers Enter into Immune Globulin Intravenous Market
Table 33. Key Manufacturers Immune Globulin Intravenous Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Immune Globulin Intravenous Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 36. Global Immune Globulin Intravenous Sales by Region (2018-2024) & (K Units)
Table 37. Global Immune Globulin Intravenous Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Immune Globulin Intravenous Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Immune Globulin Intravenous Sales Market Share in Value by Region (2018-2024)
Table 40. Global Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 41. Global Immune Globulin Intravenous Sales by Region (2024-2029) & (K Units)
Table 42. Global Immune Globulin Intravenous Sales Market Share in Volume by Region (2024-2029)
Table 43. Global Immune Globulin Intravenous Sales by Region (2024-2029) & (US$ Million)
Table 44. Global Immune Globulin Intravenous Sales Market Share in Value by Region (2024-2029)
Table 45. Global Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2029)
Table 46. Global Immune Globulin Intravenous Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 47. Global Immune Globulin Intravenous Sales by Application (2018-2024) & (K Units)
Table 48. Global Immune Globulin Intravenous Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Immune Globulin Intravenous Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Immune Globulin Intravenous Sales Market Share in Value by Application (2018-2024)
Table 51. Global Immune Globulin Intravenous Price by Application (2018-2024) & (USD/Unit)
Table 52. Global Immune Globulin Intravenous Sales by Application (2024-2029) & (K Units)
Table 53. Global Immune Globulin Intravenous Sales Market Share in Volume by Application (2024-2029)
Table 54. Global Immune Globulin Intravenous Sales by Application (2024-2029) & (US$ Million)
Table 55. Global Immune Globulin Intravenous Sales Market Share in Value by Application (2024-2029)
Table 56. Global Immune Globulin Intravenous Price by Application (2024-2029) & (USD/Unit)
Table 57. North America Immune Globulin Intravenous Sales by Application (2018-2024) (K Units)
Table 58. North America Immune Globulin Intravenous Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Immune Globulin Intravenous Sales by Application (2018-2024) (K Units)
Table 60. Europe Immune Globulin Intravenous Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Immune Globulin Intravenous Sales by Application (2018-2024) (K Units)
Table 62. Asia-Pacific Immune Globulin Intravenous Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Immune Globulin Intravenous Sales by Application (2018-2024) (K Units)
Table 64. Latin America Immune Globulin Intravenous Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Immune Globulin Intravenous Sales by Application (2018-2024) (K Units)
Table 66. Middle East and Africa Immune Globulin Intravenous Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Immune Globulin Intravenous Sales by Country (2018-2024) & (K Units)
Table 68. North America Immune Globulin Intravenous Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Immune Globulin Intravenous Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Immune Globulin Intravenous Sales Market Share in Value by Country (2018-2024)
Table 71. North America Immune Globulin Intravenous Sales by Country (2024-2029) & (K Units)
Table 72. North America Immune Globulin Intravenous Sales Market Share in Volume by Country (2024-2029)
Table 73. North America Immune Globulin Intravenous Sales by Country (2024-2029) & (US$ Million)
Table 74. North America Immune Globulin Intravenous Sales Market Share in Value by Country (2024-2029)
Table 75. Europe Immune Globulin Intravenous Sales by Country (2018-2024) & (K Units)
Table 76. Europe Immune Globulin Intravenous Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Immune Globulin Intravenous Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Immune Globulin Intravenous Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Immune Globulin Intravenous Sales by Country (2024-2029) & (K Units)
Table 80. Europe Immune Globulin Intravenous Sales Market Share in Volume by Country (2024-2029)
Table 81. Europe Immune Globulin Intravenous Sales by Country (2024-2029) & (US$ Million)
Table 82. Europe Immune Globulin Intravenous Sales Market Share in Value by Country (2024-2029)
Table 83. Asia-Pacific Immune Globulin Intravenous Sales by Region (2018-2024) & (K Units)
Table 84. Asia-Pacific Immune Globulin Intravenous Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Immune Globulin Intravenous Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Immune Globulin Intravenous Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Immune Globulin Intravenous Sales by Region (2024-2029) & (K Units)
Table 88. Asia-Pacific Immune Globulin Intravenous Sales Market Share in Volume by Region (2024-2029)
Table 89. Asia-Pacific Immune Globulin Intravenous Sales by Region (2024-2029) & (US$ Million)
Table 90. Asia-Pacific Immune Globulin Intravenous Sales Market Share in Value by Region (2024-2029)
Table 91. Latin America Immune Globulin Intravenous Sales by Country (2018-2024) & (K Units)
Table 92. Latin America Immune Globulin Intravenous Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Immune Globulin Intravenous Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Immune Globulin Intravenous Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Immune Globulin Intravenous Sales by Country (2024-2029) & (K Units)
Table 96. Latin America Immune Globulin Intravenous Sales Market Share in Volume by Country (2024-2029)
Table 97. Latin America Immune Globulin Intravenous Sales by Country (2024-2029) & (US$ Million)
Table 98. Latin America Immune Globulin Intravenous Sales Market Share in Value by Country (2024-2029)
Table 99. Middle East and Africa Immune Globulin Intravenous Sales by Country (2018-2024) & (K Units)
Table 100. Middle East and Africa Immune Globulin Intravenous Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Immune Globulin Intravenous Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Immune Globulin Intravenous Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Immune Globulin Intravenous Sales by Country (2024-2029) & (K Units)
Table 104. Middle East and Africa Immune Globulin Intravenous Sales Market Share in Volume by Country (2024-2029)
Table 105. Middle East and Africa Immune Globulin Intravenous Sales by Country (2024-2029) & (US$ Million)
Table 106. Middle East and Africa Immune Globulin Intravenous Sales Market Share in Value by Country (2024-2029)
Table 107. Takeda Company Information
Table 108. Takeda Introduction and Business Overview
Table 109. Takeda Immune Globulin Intravenous Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 110. Takeda Immune Globulin Intravenous Product
Table 111. Takeda Recent Development
Table 112. Grifols Company Information
Table 113. Grifols Introduction and Business Overview
Table 114. Grifols Immune Globulin Intravenous Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 115. Grifols Immune Globulin Intravenous Product
Table 116. Grifols Recent Development
Table 117. CSL Company Information
Table 118. CSL Introduction and Business Overview
Table 119. CSL Immune Globulin Intravenous Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 120. CSL Immune Globulin Intravenous Product
Table 121. CSL Recent Development
Table 122. Octapharma Company Information
Table 123. Octapharma Introduction and Business Overview
Table 124. Octapharma Immune Globulin Intravenous Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 125. Octapharma Immune Globulin Intravenous Product
Table 126. Octapharma Recent Development
Table 127. Biotest Company Information
Table 128. Biotest Introduction and Business Overview
Table 129. Biotest Immune Globulin Intravenous Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 130. Biotest Immune Globulin Intravenous Product
Table 131. Biotest Recent Development
Table 132. Kedrion Company Information
Table 133. Kedrion Introduction and Business Overview
Table 134. Kedrion Immune Globulin Intravenous Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 135. Kedrion Immune Globulin Intravenous Product
Table 136. Kedrion Recent Development
Table 137. Hualan Bio Company Information
Table 138. Hualan Bio Introduction and Business Overview
Table 139. Hualan Bio Immune Globulin Intravenous Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 140. Hualan Bio Immune Globulin Intravenous Product
Table 141. Hualan Bio Recent Development
Table 142. CNBG Company Information
Table 143. CNBG Introduction and Business Overview
Table 144. CNBG Immune Globulin Intravenous Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 145. CNBG Immune Globulin Intravenous Product
Table 146. CNBG Recent Development
Table 147. Shanghai RAAS Company Information
Table 148. Shanghai RAAS Introduction and Business Overview
Table 149. Shanghai RAAS Immune Globulin Intravenous Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 150. Shanghai RAAS Immune Globulin Intravenous Product
Table 151. Shanghai RAAS Recent Development
Table 152. CBPO Company Information
Table 153. CBPO Introduction and Business Overview
Table 154. CBPO Immune Globulin Intravenous Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 155. CBPO Immune Globulin Intravenous Product
Table 156. CBPO Recent Development
Table 157. LFB Group Company Information
Table 158. LFB Group Introduction and Business Overview
Table 159. LFB Group Immune Globulin Intravenous Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 160. LFB Group Immune Globulin Intravenous Product
Table 161. LFB Group Recent Development
Table 162. BPL Company Information
Table 163. BPL Introduction and Business Overview
Table 164. BPL Immune Globulin Intravenous Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 165. BPL Immune Globulin Intravenous Product
Table 166. BPL Recent Development
Table 167. Sichuan Yuanda Shuyang Company Information
Table 168. Sichuan Yuanda Shuyang Introduction and Business Overview
Table 169. Sichuan Yuanda Shuyang Immune Globulin Intravenous Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 170. Sichuan Yuanda Shuyang Immune Globulin Intravenous Product
Table 171. Sichuan Yuanda Shuyang Recent Development
Table 172. Key Raw Materials Lists
Table 173. Raw Materials Key Suppliers Lists
Table 174. Immune Globulin Intravenous Market Trends
Table 175. Immune Globulin Intravenous Market Drivers
Table 176. Immune Globulin Intravenous Market Challenges
Table 177. Immune Globulin Intravenous Market Restraints
Table 178. Immune Globulin Intravenous Distributors List
Table 179. Immune Globulin Intravenous Downstream Customers
Table 180. Research Programs/Design for This Report
Table 181. Key Data Information from Secondary Sources
Table 182. Key Data Information from Primary Sources
List of Figures
Figure 1. Immune Globulin Intravenous Product Picture
Figure 2. Global Immune Globulin Intravenous Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Immune Globulin Intravenous Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Immune Globulin Intravenous Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of IVIg Liquid
Figure 6. Global IVIg Liquid Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of IVIg Powder
Figure 8. Global IVIg Powder Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Global Immune Globulin Intravenous Sales by Type (2018-2029) & (US$ Million)
Figure 10. Global Immune Globulin Intravenous Sales Market Share by Type in 2022 & 2029
Figure 11. North America Immune Globulin Intravenous Sales Market Share in Volume by Type in 2022
Figure 12. North America Immune Globulin Intravenous Sales Market Share in Value by Type in 2022
Figure 13. Europe Immune Globulin Intravenous Sales Market Share in Volume by Type in 2022
Figure 14. Europe Immune Globulin Intravenous Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Immune Globulin Intravenous Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Immune Globulin Intravenous Sales Market Share in Value by Type in 2022
Figure 17. Latin America Immune Globulin Intravenous Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Immune Globulin Intravenous Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Immune Globulin Intravenous Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Immune Globulin Intravenous Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Immune Globulin Intravenous Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Immune Globulin Intravenous Revenue in 2022
Figure 23. Immune Globulin Intravenous Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Immunodeficiency
Figure 25. Global Immunodeficiency Sales YoY Growth (2018-2029) & (K Units)
Figure 26. Product Picture of Autoimmune Disease
Figure 27. Global Autoimmune Disease Sales YoY Growth (2018-2029) & (K Units)
Figure 28. Product Picture of Acute Infection
Figure 29. Global Acute Infection Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Global Immune Globulin Intravenous Sales by Application (2018-2029) & (US$ Million)
Figure 31. Global Immune Globulin Intravenous Sales Market Share by Application in 2022 & 2029
Figure 32. North America Immune Globulin Intravenous Sales Market Share in Volume by Application in 2022
Figure 33. North America Immune Globulin Intravenous Sales Market Share in Value by Application in 2022
Figure 34. Europe Immune Globulin Intravenous Sales Market Share in Volume by Application in 2022
Figure 35. Europe Immune Globulin Intravenous Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Immune Globulin Intravenous Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Immune Globulin Intravenous Sales Market Share in Value by Application in 2022
Figure 38. Latin America Immune Globulin Intravenous Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Immune Globulin Intravenous Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Immune Globulin Intravenous Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Immune Globulin Intravenous Manufacturing Cost Structure
Figure 43. Immune Globulin Intravenous Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed